Occurrence of Antibodies against SARS-CoV-2 in the Domestic Cat Population of Germany

被引:82
|
作者
Michelitsch, Anna [1 ]
Hoffmann, Donata [1 ]
Wernike, Kerstin [1 ]
Beer, Martin [1 ]
机构
[1] Friedrich Loeffer Inst, Inst Diagnost Virol, D-17493 Greifswald, Germany
关键词
SARS-CoV-2; domestic cat; sero-prevalence; COVID-19; diagnostics; serology; felines; Germany; INFECTION;
D O I
10.3390/vaccines8040772
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Domestic cats (Felis catus) are popular companion animals that live in close contact with their human owners. Therefore, the risk of a trans-species spreading event between domestic cats and humans is ever-present. Shortly after the emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its rapid spread around the world, the role of domestic cats in the transmission cycle was questioned. In the present study, the first large-scale survey of antibody occurrence in the domestic cat population in Germany was conducted, in order to assess the incidence of naturally occurring human to cat transmission of SARS-CoV-2. A total of 920 serum samples, which were collected from April to September of 2020, were screened by an indirect multispecies ELISA. Positive samples were verified using an indirect immunofluorescence test (iIFT) and additionally tested for neutralizing antibodies. Furthermore, serum samples were screened for antibodies against feline coronavirus (FCoV), in order to rule out cross-reactivity in the described test systems. Overall, 0.69% (6/920) of serum samples were found to be positive for antibodies against SARS-CoV-2 by ELISA and iIFT. Two of these reactive sera also displayed neutralizing antibodies. No cross-reactivity with FCoV-specific antibodies was observed. The finding of SARS-CoV-2 antibody-positive serum samples in the domestic cat population of Germany, during a period when the incidence of human infection in the country was still rather low, indicates that human-to-cat transmission of SARS-CoV-2 happens, but there is no indication of SARS-CoV-2 circulation in cats.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 50 条
  • [1] The Second Wave of SARS-CoV-2 Circulation-Antibody Detection in the Domestic Cat Population in Germany
    Michelitsch, Anna
    Schon, Jacob
    Hoffmann, Donata
    Beer, Martin
    Wernike, Kerstin
    [J]. VIRUSES-BASEL, 2021, 13 (06):
  • [2] Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021
    Tunheim, Gro
    Ro, Gunnar Oyvind Isaksson
    Chopra, Adity
    Aase, Audun
    Kran, Anne-Marte Bakken
    Vaage, John Torgils
    Lund-Johansen, Fridtjof
    Hungnes, Olav
    [J]. INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (06) : 1004 - 1013
  • [3] Antibodies against SARS-CoV-2 Suggestive of Single Events of Spillover to Cattle, Germany
    Wernike, Kerstin
    Boettcher, Jens
    Amelung, Silke
    Albrecht, Kerstin
    Gartner, Tanja
    Donat, Karsten
    Beer, Martin
    [J]. EMERGING INFECTIOUS DISEASES, 2022, 28 (09) : 1916 - 1918
  • [4] Neutralizing and enhancing antibodies against SARS-CoV-2
    Liu, Yafei
    Arase, Hisashi
    [J]. INFLAMMATION AND REGENERATION, 2022, 42 (01)
  • [5] Neutralizing and enhancing antibodies against SARS-CoV-2
    Yafei Liu
    Hisashi Arase
    [J]. Inflammation and Regeneration, 42
  • [6] Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil
    Silveira, Mariangela F.
    Barros, Aluisio J. D.
    Horta, Bernardo L.
    Pellanda, Lucia C.
    Victora, Gabriel D.
    Dellagostin, Odir A.
    Struchiner, Claudio J.
    Burattini, Marcelo N.
    Valim, Andreia R. M.
    Berlezi, Evelise M.
    Mesa, Jeovany M.
    Ikeda, Maria Leticia R.
    Mesenburg, Marilia A.
    Mantesso, Marina
    Dall'Agnol, Marinel M.
    Bittencourt, Raqueli A.
    Hartwig, Fernando P.
    Menezes, Ana M. B.
    Barros, Fernando C.
    Hallal, Pedro C.
    Victora, Cesar G.
    [J]. NATURE MEDICINE, 2020, 26 (08) : 1196 - +
  • [7] Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil
    Mariângela F. Silveira
    Aluísio J. D. Barros
    Bernardo L. Horta
    Lúcia C. Pellanda
    Gabriel D. Victora
    Odir A. Dellagostin
    Claudio J. Struchiner
    Marcelo N. Burattini
    Andréia R. M. Valim
    Evelise M. Berlezi
    Jeovany M. Mesa
    Maria Letícia R. Ikeda
    Marilia A. Mesenburg
    Marina Mantesso
    Marinel M. Dall’Agnol
    Raqueli A. Bittencourt
    Fernando P. Hartwig
    Ana M. B. Menezes
    Fernando C. Barros
    Pedro C. Hallal
    Cesar G. Victora
    [J]. Nature Medicine, 2020, 26 : 1196 - 1199
  • [8] Safety and Efficacy of Monoclonal Antibodies Against Sars-Cov-2 in a Heart Transplant Population
    Brink, H.
    Stoller, D.
    Lowes, B.
    Lundgren, S.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S193 - S193
  • [9] Duration of SARS-CoV-2 Serum-Neutralizing Antibodies Against SARS-CoV-2 Dependent on the Individual
    Li, Jin
    Zou, Li
    Li, Shaojie
    Zou, Ruogu
    Fang, Zhixiong
    Zhang, Pingan
    Li, Huijun
    Wang, Shanshan
    Ke, Dong
    Gao, Peng
    Jin, Cuicui
    Fang, Cong
    Zhou, Ji
    He, Ellen
    Skog, Sven
    [J]. VIRAL IMMUNOLOGY, 2023, 36 (03) : 153 - 162
  • [10] Immunity Against SARS-CoV-2 in the German Population
    Schulze-Wundling, Kai
    Ottensmeyer, Patrick Frank
    Meyer-Schlinkmann, Kristin Maria
    Deckena, Marek
    Krueger, Stefan
    Schlinkert, Simon
    Budde, Axel
    Muenstermann, Dieter
    Toepfner, Nicole
    Petersmann, Astrid
    Nauck, Matthias
    Karch, Andre
    Lange, Berit
    Blaschke, Sabine
    Tiemann, Carsten
    Streeck, Hendrik
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2023, 120 (19): : 337 - +